Robuta

https://www.news-medical.net/news/20240703/Exercise-boosts-tumor-killing-white-blood-cells-in-breast-cancer-patients.aspx?ref=lavieensante.com
A new Finnish study from University of Turku shows that already a 30-minute exercise can increase the proportion of tumor-killing white blood cells in the...
white blood cellsbreast cancerexercisebooststumor
https://www.prnewswire.com/news-releases/natera-chosen-for-longitudinal-circulating-tumor-dna-study-in-breast-cancer-300547101.html
/PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Imperial College...
circulating tumor dnanaterachosenlongitudinalstudy
https://pubmed.ncbi.nlm.nih.gov/27931250/
Single-cell sequencing of bone marrow epithelial-like cells, in parallel with intra-tumor genetic heterogeneity profiling from bulk DNA, is a powerful approach...
the origintumor cellsbreast cancertracingdisseminated
https://pubmed.ncbi.nlm.nih.gov/38460249/
ctDNA detection was associated with worse DFS and OS in patients with operable BC, particularly when detected after treatment and using primary tumor-informed...
circulating tumor dnapredictingrecurrencepatientsoperable
https://ieeexplore.ieee.org/document/9776554/
In breast-conserving operations, terahertz imaging (THz) has become a popular method of assessing tumor margins intraoperatively. Typically, THz measurements ar
for exbreast cancersubterahertzwaveguide
https://pubmed.ncbi.nlm.nih.gov/24995409/
To evaluate retrospectively rates of local (LCR) and locoregional tumor control (LRCR) in patients with locally advanced breast cancer (LABC) who were treated...
ioertanticipatedtumorbedboost
https://pubmed.ncbi.nlm.nih.gov/31415379/
Conventional therapy modalities for advanced breast cancer are problematic, whereas checkpoint blockade immunotherapy has been considered as a promising...
primary tumorbreast cancerresectioninitiallystaged
https://www.scarymommy.com/breast-cancer-drug-enhertu-72-percent
A new breast cancer drug from AstraZeneca called Enhertu reduces the risk of death or tumor progression by 72 percent.
new breastcancer drugreducesriskdeath
https://www.sciencedaily.com/releases/2024/07/240724171509.htm
A new machine-learning model can identify the stage of disease in ductal carcinoma in situ, a type of preinvasive tumor that can sometimes progress to a deadly...
ai modelbreast tumorcertainstageslikely